Bortezomib combined with chemotherapy in adults with relapsed/refractory acute lymphoblastic leukemia

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
This article has no abstract
Epistemonikos ID: 52eac0d9beecac18de5b3985b8a03c0f3bf4f97f
First added on: Apr 08, 2025